Hooman Izadi

452 total citations
16 papers, 373 citations indexed

About

Hooman Izadi is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Hooman Izadi has authored 16 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Immunology and 4 papers in Infectious Diseases. Recurrent topics in Hooman Izadi's work include Vector-borne infectious diseases (3 papers), CRISPR and Genetic Engineering (3 papers) and Viral Infections and Vectors (3 papers). Hooman Izadi is often cited by papers focused on Vector-borne infectious diseases (3 papers), CRISPR and Genetic Engineering (3 papers) and Viral Infections and Vectors (3 papers). Hooman Izadi collaborates with scholars based in United States, Spain and Iran. Hooman Izadi's co-authors include Juan Anguíta, Chris M. Olson, Tonya C. Bates, Elı́as R. Olivera, Michael N. Hedrick, Justin D. Radolf, Jonathan E. Boyson, Sally A. Huber, Utpal Pal and Nicolás Navasa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Hooman Izadi

14 papers receiving 371 citations

Peers

Countries citing papers authored by Hooman Izadi

Since Specialization

Citations

This map shows the geographic impact of Hooman Izadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hooman Izadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hooman Izadi more than expected).

Fields of papers citing papers by Hooman Izadi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hooman Izadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hooman Izadi. The network helps show where Hooman Izadi may publish in the future.

Co-authorship network of co-authors of Hooman Izadi

This figure shows the co-authorship network connecting the top 25 collaborators of Hooman Izadi. A scholar is included among the top collaborators of Hooman Izadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hooman Izadi. Hooman Izadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	The Selective WEE1 Inhibitor Azenosertib Shows Synergistic Antitumor Activity with KRAS G12C Inhibitors in Preclinical Models 2025 ·Cancer Research Communications ·Nathan M. Jameson, (unknown), Catherine Lee, (unknown), (unknown), Xiao Guo, Hooman Izadi, (unknown), Olivier Harismendy, Jianhui Ma, (unknown), (unknown)	3
2	Discovery of ZN-c5, an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) with Improved Pharmacokinetics 2025 ·Journal of Medicinal Chemistry ·Sayee G. Hegde, (unknown), Kevin D. Bunker, (unknown), Deborah H. Slee, Mehmet Kahraman, (unknown), Rakesh K. Sit, Christian C. Lee, (unknown), Ahmed A. Samatar, Jiali Li, Jianhui Ma, Hooman Izadi, (unknown), Alex Chao	0
3	Abstract 2153: Cyclin E1 protein overexpression sensitizes ovarian cancer cells to ZN-c3, a novel, selective and oral bioavailable inhibitor of Wee1 2023 ·Cancer Research ·(unknown), Wen Liu, Heekyung Chung, Hooman Izadi, (unknown), Olivier Harismendy, Jia Li, Fernando Doñate, Ahmed A. Samatar, Mark R. Lackner, (unknown), Kevin D. Bunker, Dae‐Hwan Kim, Nathan M. Jameson, (unknown), Kangjin Jeong, Dong Zhang, (unknown), Gordon B. Mills	3
4	Sgr-2921, a Potent CDC7 Inhibitor, Demonstrates Significant Anti-Leukemic Responses in Patient-Derived AML Models Representing Difficult-to-Treat Disease 2023 ·Blood ·Hooman Izadi, (unknown), Christian Atsriku, (unknown), Adam Levinson, Joseph R. Piccotti, Steven Pirie‐Shepherd, Lin Tang, (unknown), Karen Akinsanya, (unknown), (unknown)	1
5	Rumen‐protected l‐carnitine supplementation during mating period altered metabolic status and reproductive performance of ewes 2023 ·Journal of Animal Physiology and Animal Nutrition ·(unknown), (unknown), Ali Javadmanesh, (unknown), Hooman Izadi, Mohsen Danesh Mesgaran	1
6	Abstract 2606: ZN-c3, a potent and selective Wee-1 inhibitor demonstrates anti-tumor activities in combination with other targeted therapies and overcomes PARP inhibitor resistance 2022 ·Cancer Research ·Jiali Li, (unknown), Petrus R. de Jong, Hooman Izadi, (unknown), (unknown), Brant C. Boren, (unknown), Fernando Doñate, Ahmed A. Samatar	2
7	Abstract 2591: Combination of the BCL-2 inhibitor ZN-d5 with the WEE1 inhibitor ZN-c3 shows additive or synergistic anti-tumor activity in acute myeloid leukemia (AML) models 2022 ·Cancer Research ·Hooman Izadi, (unknown), (unknown), (unknown), Brant C. Boren, (unknown), Petrus R. de Jong, Jiali Li, Kevin D. Bunker, Ahmed A. Samatar, Fernando Doñate	1
8	528P Discovery of ZN-d5, a potent BCL-2 inhibitor with improved selectivity for BCL-2 2021 ·Annals of Oncology ·(unknown), Hooman Izadi, (unknown), Nurhadi Ibrahim, Kevin D. Bunker, Fernando Doñate, Ahmed A. Samatar, (unknown)	3
9	Abstract 4707: Evaluation of efficacy and immune response to PD1 checkpoint inhibition in human immune-reconstituted mice using patient-derived xenograft models 2017 ·Cancer Research ·Hooman Izadi, (unknown), (unknown), Jayant Thatte	1
10	Ikaros mediates the DNA methylation-independent silencing of MCJ/DNAJC15 gene expression in macrophages 2015 ·Scientific Reports ·Nicolás Navasa, Itziar Martín‐Ruiz, (unknown), James D. Sutherland, (unknown), (unknown), Hooman Izadi, Julen Tomás‐Cortázar, Furkan Ayaz, Natalia Martín-Martín, (unknown), Rosa Barrio, Arkaitz Carracedo, Elı́as R. Olivera, Mercedes Rincón, Juan Anguíta	14
11	Regulation of Oxidative Stress by Methylation-Controlled J Protein Controls Macrophage Responses to Inflammatory Insults 2014 ·The Journal of Infectious Diseases ·Nicolás Navasa, Itziar Serna Martin, Juan Manuel Iglesias‐Pedraz, Naiara Beraza, (unknown), Hooman Izadi, Furkan Ayaz, (unknown), (unknown), (unknown), Oliver Dienz, Barbara A. Osborne, Maria Luz Martínez‐Chantar, Mercedes Rincón, Juan Anguíta	20
12	CD14 cooperates with complement receptor 3 to mediate MyD88-independent phagocytosis ofBorrelia burgdorferi 2012 ·Proceedings of the National Academy of Sciences ·Kelly L. Hawley, Chris M. Olson, Juan Manuel Iglesias‐Pedraz, Nicolás Navasa, Jorge Cervantes, Melissa J. Caimano, Hooman Izadi, Robin R. Ingalls, Utpal Pal, Juan C. Salazar, Justin D. Radolf, Juan Anguíta	56
13	Local Production of IFN-γ by Invariant NKT Cells Modulates Acute Lyme Carditis 2009 ·The Journal of Immunology ·Chris M. Olson, Tonya C. Bates, Hooman Izadi, Justin D. Radolf, Sally A. Huber, Jonathan E. Boyson, Juan Anguíta	84
14	Borrelia burgdorferi lipoprotein BmpA activates pro-inflammatory responses in human synovial cells through a protein moiety 2008 ·Microbes and Infection ·Xiuli Yang, Hooman Izadi, Adam S. Coleman, Penghua Wang, (unknown), Erol Fikrig, Juan Anguíta, Utpal Pal	29
15	c-Jun N-Terminal Kinase 1 Is Required for Toll-Like Receptor 1 Gene Expression in Macrophages 2007 ·Infection and Immunity ·Hooman Izadi, (unknown), Tonya C. Bates, Elı́as R. Olivera, Vega Villar‐Suárez, Ila Joshi, Renu Garg, Barbara A. Osborne, Roger J. Davis, Mercedes Rincón, Juan Anguíta	21
16	p38 Mitogen-Activated Protein Kinase Controls NF-κB Transcriptional Activation and Tumor Necrosis Factor Alpha Production through RelA Phosphorylation Mediated by Mitogen- and Stress-Activated Protein Kinase 1 in Response toBorrelia burgdorferiAntigens 2006 ·Infection and Immunity ·Chris M. Olson, Michael N. Hedrick, Hooman Izadi, Tonya C. Bates, Elı́as R. Olivera, Juan Anguíta	134

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact